LFB BIOMANUFACTURING is committed in innovating for tomorrow, namely by using single use equipment to optimize flexibility, and its ability to meet the customers’s demand in terms of scale-up, volume and cost control LFB BIOMANUFACTURING’s facility offers more flexibility with single use-oriented cutting-edge equipment.
LFB BIOMANUFACTURING is also expanding its GMP facilities to provide a three-fold increase in the Alès’ site multi-product manufacturing capacity from 2017, and the goal is to operate a ten-fold increase around 2020, depending on LFB BIOMANUFACTURING’s growth.
Single use -oriented cutting edge equipment
Currently, LFB BIOMANUFACTURING owns a wide range of single use bioreactor platforms and cell culture systems including:
- Cell factories for adherent cells
- Roller bottle systems
- Wave reactors
- Single-use bioreactors from 50L up to 1000L
A flexible facility at the highest technical and quality standards
An additional production suite running multiple, with bioreactors of 2000L is being equipped to be operational soon. This new unit will be a DSP/USP multiproduct facility for customer’s project and LFB’s projects. The site will offer a flexible facility, at the highest global standards of the field and with a compliance to European and American regulatory requirements.